PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.

Abstract This article reviews essential topics of canine visceral leishmaniasis (CVL) due to Leishmania infantum infection. It focuses on the current serological and molecular diagnostic methods used in epidemiological research and veterinary clinics to diagnose CVL and includes new point-of-care (POC) tests under development. The efficacy of different treatment regimens on the clinical improvement and infectiousness of dogs is also addressed. In the last section, the review provides a critical appraisal of the effectiveness of different control measures that have been implemented to curb disease transmission.
PMID
Related Publications

A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis.

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.

Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.

In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.

Authors

Mayor MeshTerms

Molecular Diagnostic Techniques

Keywords
Journal Title plos neglected tropical diseases
Publication Year Start




PMID- 29324838
OWN - NLM
STAT- MEDLINE
DCOM- 20180130
LR  - 20180130
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 12
IP  - 1
DP  - 2018 Jan
TI  - Canine visceral leishmaniasis: Diagnosis and management of the reservoir living
      among us.
PG  - e0006082
LID - 10.1371/journal.pntd.0006082 [doi]
AB  - This article reviews essential topics of canine visceral leishmaniasis (CVL) due 
      to Leishmania infantum infection. It focuses on the current serological and
      molecular diagnostic methods used in epidemiological research and veterinary
      clinics to diagnose CVL and includes new point-of-care (POC) tests under
      development. The efficacy of different treatment regimens on the clinical
      improvement and infectiousness of dogs is also addressed. In the last section,
      the review provides a critical appraisal of the effectiveness of different
      control measures that have been implemented to curb disease transmission.
FAU - Travi, Bruno L
AU  - Travi BL
AUID- ORCID: 0000-0003-4160-302X
AD  - Department of Internal Medicine-Division of Infectious Diseases, University of
      Texas Medical Branch, Galveston, Texas, United States of America.
FAU - Cordeiro-da-Silva, Anabela
AU  - Cordeiro-da-Silva A
AD  - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto, Porto,
      Portugal.
AD  - Parasite Disease Group, Instituto de Biologia Molecular e Celular, Universidade
      do Porto, Porto, Portugal.
AD  - Departamento de Ciencias Biologicas, Faculdade de Farmacia da Universidade do
      Porto, Porto, Portugal.
FAU - Dantas-Torres, Filipe
AU  - Dantas-Torres F
AD  - Department of Immunology, Aggeu Magalhaes Institute, Oswaldo Cruz Foundation,
      Recife, Pernambuco, Brazil.
FAU - Miro, Guadalupe
AU  - Miro G
AD  - Veterinary Faculty, Animal Health Department, Universidad Complutense de Madrid, 
      Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20180111
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
RN  - 0 (Antiprotozoal Agents)
RN  - 0 (Organometallic Compounds)
RN  - 107-73-3 (Phosphorylcholine)
RN  - 53EY29W7EC (miltefosine)
RN  - 63CZ7GJN5I (Allopurinol)
RN  - 6HG8UB2MUY (Meglumine)
RN  - 75G4TW236W (meglumine antimoniate)
SB  - IM
MH  - Allopurinol/therapeutic use
MH  - Animals
MH  - Antiprotozoal Agents/*therapeutic use
MH  - Disease Reservoirs/parasitology/veterinary
MH  - Dog Diseases/*diagnosis/*drug therapy/parasitology
MH  - Dogs
MH  - Leishmania infantum/drug effects
MH  - Leishmaniasis, Visceral/*diagnosis/parasitology/*veterinary
MH  - Meglumine/therapeutic use
MH  - *Molecular Diagnostic Techniques
MH  - Organometallic Compounds/therapeutic use
MH  - Phosphorylcholine/analogs & derivatives/therapeutic use
MH  - Point-of-Care Systems
MH  - Serologic Tests
PMC - PMC5764232
EDAT- 2018/01/13 06:00
MHDA- 2018/01/31 06:00
CRDT- 2018/01/12 06:00
PHST- 2018/01/12 06:00 [entrez]
PHST- 2018/01/13 06:00 [pubmed]
PHST- 2018/01/31 06:00 [medline]
AID - 10.1371/journal.pntd.0006082 [doi]
AID - PNTD-D-17-01146 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006082. doi:
      10.1371/journal.pntd.0006082. eCollection 2018 Jan.